REPORT ID 411

Global Ophthalmic Therapeutic Drugs Sales Market Report 2017

Publish Date
01-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the global Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Ophthalmic Therapeutic Drugs market competition by top manufacturers/players, with Ophthalmic Therapeutic Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer
    Pfizer
    Novartis
    ALLERGAN
    Aerie Pharmaceuticals
    Valeant Pharmaceuticals International
    Genentech
    Regeneron Pharmaceuticals
    Shire
    Santen Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    by Therapeutic Class
        Anti-inflammatory Drugs
        Anti-infective Drugs
        Anti-glaucoma Drugs
        Anti-allergy Drugs
        Anti-VEGF Agents
        Others
    by Product Type
        Prescription Drugs
        Over-the-Counter Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Ophthalmic Therapeutic Drugs Sales Market Report 2017
1 Ophthalmic Therapeutic Drugs Market Overview
    1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
    1.2 Classification of Ophthalmic Therapeutic Drugs by Product Category
        1.2.1 Global Ophthalmic Therapeutic Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Ophthalmic Therapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-inflammatory Drugs
        1.2.4 Anti-infective Drugs
        1.2.5 Anti-glaucoma Drugs
        1.2.6 Anti-allergy Drugs
        1.2.7 Anti-VEGF Agents
        1.2.8 Others
    1.3 Global Ophthalmic Therapeutic Drugs Market by Application/End Users
        1.3.1 Global Ophthalmic Therapeutic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Independent Pharmacies & Drug Stores
    1.4 Global Ophthalmic Therapeutic Drugs Market by Region
        1.4.1 Global Ophthalmic Therapeutic Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
        1.4.3 China Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
        1.4.4 Europe Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
        1.4.5 Japan Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
        1.4.7 India Ophthalmic Therapeutic Drugs Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Ophthalmic Therapeutic Drugs (2012-2022)
        1.5.1 Global Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2022)

2 Global Ophthalmic Therapeutic Drugs Competition by Players/Suppliers, Type and Application
     2.1 Global Ophthalmic Therapeutic Drugs Market Competition by Players/Suppliers
        2.1.1 Global Ophthalmic Therapeutic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Ophthalmic Therapeutic Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Ophthalmic Therapeutic Drugs (Volume and Value) by Type
        2.2.1 Global Ophthalmic Therapeutic Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Ophthalmic Therapeutic Drugs (Volume and Value) by Region
        2.3.1 Global Ophthalmic Therapeutic Drugs Sales and Market Share by Region (2012-2017)
        2.3.2 Global Ophthalmic Therapeutic Drugs Revenue and Market Share by Region (2012-2017)
    2.4 Global Ophthalmic Therapeutic Drugs (Volume) by Application

3 United States Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    3.1 United States Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        3.1.1 United States Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    3.2 United States Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    3.3 United States Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    3.4 United States Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

4 China Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    4.1 China Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        4.1.1 China Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    4.2 China Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    4.3 China Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    4.4 China Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

5 Europe Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    5.1 Europe Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        5.1.1 Europe Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    5.2 Europe Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    5.3 Europe Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    5.4 Europe Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

6 Japan Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    6.1 Japan Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        6.1.1 Japan Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    6.2 Japan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    6.3 Japan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    6.4 Japan Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

7 Southeast Asia Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    7.3 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    7.4 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

8 India Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price)
    8.1 India Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        8.1.1 India Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Ophthalmic Therapeutic Drugs Sales Price Trend (2012-2017)
    8.2 India Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Players
    8.3 India Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Type
    8.4 India Ophthalmic Therapeutic Drugs Sales Volume and Market Share by Application

9 Global Ophthalmic Therapeutic Drugs Players/Suppliers Profiles and Sales Data
    9.1 Bayer
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Bayer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Pfizer
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Novartis
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Novartis Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 ALLERGAN
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Aerie Pharmaceuticals
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Valeant Pharmaceuticals International
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Genentech
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Genentech Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Regeneron Pharmaceuticals
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Shire
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Shire Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Santen Pharmaceutical
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview

10 Ophthalmic Therapeutic Drugs Maufacturing Cost Analysis
    10.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs
    10.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Ophthalmic Therapeutic Drugs Market Forecast (2017-2022)
    14.1 Global Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Ophthalmic Therapeutic Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Ophthalmic Therapeutic Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Ophthalmic Therapeutic Drugs Sales Forecast by Type (2017-2022)
       14.3.2 Global Ophthalmic Therapeutic Drugs Revenue Forecast by Type (2017-2022)
       14.3.3 Global Ophthalmic Therapeutic Drugs Price Forecast by Type (2017-2022)
    14.4 Global Ophthalmic Therapeutic Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer